Abstract

A new alkaloid paenidigyamycin A (1) was obtained from the novel Ghanaian Paenibacillus sp. isolated from the mangrove rhizosphere soils of the Pterocarpus santalinoides tree growing in the wetlands of the Digya National Park, Ghana. Compound 1 was isolated on HPLC at tR = 37.0 min and its structure determined by MS, 1D, and 2D-NMR data. When tested against L. major, 1 (IC50 0.75 µM) was just as effective as amphotericin B (IC50 0.31 µM). Against L. donovani, 1 (IC50 7.02 µM) was twenty-two times less active than amphotericin B (IC50 0.32 µM), reinforcing the unique effectiveness of 1 against L. major. For T. brucei brucei, 1 (IC50 0.78 µM) was ten times more active than the laboratory standard Coptis japonica (IC50 8.20 µM). The IC50 of 9.08 µM for 1 against P. falciparum 3d7 compared to artesunate (IC50 36 nM) was not strong, but this result suggests the possibility of using the paenidigyamycin scaffold for the development of potent antimalarial drugs. Against cercariae, 1 showed high anticercaricidal activity compared to artesunate. The minimal lethal concentration (MLC) and minimal effective concentration (MEC) of the compound were 25 and 6.25 µM, respectively, while artesunate was needed in higher quantities to produce such results. However, 1 (IC50 > 100 µM) was not active against T. mobilensis.

Highlights

  • Sub-Sahara Africa (SSA) is burdened with a high incidence of parasitic infections, including schistosomiasis, trypanosomiasis, trichomoniasis, and leishmaniasis [1,2,3]

  • Volta ensures that thein area by of this rhizosphere soilstributaries of the Pterocarpus tree growing the occupied wetland areas thetree is covered with water throughout

  • (16.44 μM), and 180 min (15.08 μM). These results suggest that the paenidigyamycin scaffold could μM), 120 mins (20.2 μM), 150 min (16.44 μM), and 180 min (15.08 μM)

Read more

Summary

Introduction

Sub-Sahara Africa (SSA) is burdened with a high incidence of parasitic infections, including schistosomiasis, trypanosomiasis, trichomoniasis, and leishmaniasis [1,2,3]. PNTDonly drugs only treat stages parasite development, thereby complicating the the treatment routines specificof stages of parasite development, thereby complicating treatment routinesfor forpatients patients and and preventing complete parasite removal from the body [10,11]. Due to their long time prevalence in preventing complete parasite removal from the body [10,11]. In the last last four four years, years, we we have have collected collected several several soils soils and and sediments sediments from from unexplored unexplored unique unique From these environments in the Ghanaian Western, Volta, and Brong Ahafo Regional wetlands.

Sediment
Taxonomy
Neighbour-joining phylogenetic basedon on16S
General Experimental Procedures
Identification of Strain DE2SH
Fermentation
Extraction and Purification
Bioassay Reagents
Compound Preparation for Bioassay
Cell Culture
Preparation of Cercarial Suspension
Screening for Anti-Malaria Activity Using the SYBR Green I Assay
In Vitro Viability Test for Trypanosome Parasites
In Vitro Viability Test for Leishmania Parasites
In Vitro Cercariacidal Activity Test
In-Vitro Susceptibility Testing of Trichomonas Mobilensis
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.